Physician profile
Karin Riggs
NPI 1801897558
$806.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $85.65 · 2022: $360.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $161.63 | 2019-2020 | |
| Corium, LLC | $132.61 | 2022 | |
| Sanofi Pasteur INC. | $111.36 | 2019-2022 | |
| Novo Nordisk INC | $63.99 | 2019-2022 | |
| Abbvie INC. | $52.72 | 2022 | |
| Allergan, INC. | $50.11 | 2019-2020 | |
| Lilly USA, LLC | $48.66 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.08 | 2022 | |
| Daiichi Sankyo INC. | $34.69 | 2022 | |
| Merck Sharp & Dohme LLC | $30.55 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $22.38 | 2022 | |
| Ironshore Pharmaceuticals INC. | $17.28 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.07 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.78 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $11.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karin Riggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.